New Vioxx study projects cases of heart attacks
Wall Street Journal (subscription required), Oct. 6, 2004
A study led by an FDA safety official projects that the widespread use of Vioxx may have led to more than 27,000 heart attacks and sudden cardiac deaths before the drug's abrupt withdrawal by Merck & Co. The analysis specifically finds that from Vioxx's approval in 1999, through 2003, an estimated 27,785 heart attacks and sudden cardiac deaths "would have been avoided" had Pfizer Inc.'s Celebrex been used instead of Vioxx.
Would you like to comment?
